echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: BNT162b2 vaccination booster can reduce the risk of death from new coronary pneumonia by 90%

    NEJM: BNT162b2 vaccination booster can reduce the risk of death from new coronary pneumonia by 90%

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Mass vaccination of the new crown vaccine has significantly reduced the risk of death for patients with new crown pneumonia


    The new crown pneumonia recently researchers examined the effect of intensive vaccination against Israel's new crown pneumonia mortality


    The researchers collected data on people over 50 in the Clalit database.


    A total of 843208 participant data were collected, of which 758118 (90%) received booster injections during the 54-day study period


    65 participants in the strengthening group and 137 participants in the control group died due to Covid-19 (the risk of death was 0.


    Intensified needles significantly reduce the risk of death from new coronary pneumonia

    Intensified needle significantly reduces the risk of death from new coronary pneumonia Enhanced needle greatly reduces the risk of death from new coronary pneumonia

    Studies believe that in people who have completed the BNT162b2 vaccination for at least 5 months, the third shot can reduce the risk of death from new coronary pneumonia by 90%


    In people who have completed the BNT162b2 vaccination for at least 5 months, the third shot can reduce the risk of death from new coronary pneumonia by 90%


    Ronen Arbel et al.


    BNT162b2 Vaccine Booster and Mortality Due to Covid-19.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.